Oxford BioDynamics PLC - biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform - Reports that Vulpes Testudo Fund, controlled by Non-Executive Director.
(Bloomberg) Singapore should be the obvious winner from the gradual demise of Hong Kong as Asia’s top finance hub. It’s not quite working out that way so far.